CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection

  1. Kyoto Matsudo
  2. Kazuki Takada
  3. Asato Hashinokuchi
  4. Taichi Nagano
  5. Fumihiko Kinoshita
  6. Takaki Akamine
  7. Mikihiro Kohno
  8. Tomoyoshi Takenaka
  9. Mototsugu Shimokawa
  10. Yoshinao Oda
  11. Tomoharu Yoshizumi
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s10147-025-02771-9
  2. Version published to 10.21203/rs.3.rs-5910517/v1 on Research Square